Comparing visual outcomes of nAMD treatment during and after the COVID-19 restrictions period
Patients diagnosed during the COVID-19 restrictions period had worse visual outcomes than those diagnosed thereafter. Multiple factors, including, but not limited to reduced treatment frequency, likely contributed to worse visual outcomes.
Authors
- Jeanette Du (ORCID: https://orcid.org/0000-0001-6607-5660)
- Mike Y Chen
- Mohsin Ali (ORCID: https://orcid.org/0000-0002-1077-2341)
- K. Brian (ORCID: https://orcid.org/0000-0003-1707-6899)
Institutions
- Georgetown University (US)
- Elman Retina Group (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-05-07
- DOI
- https://doi.org/10.1371/journal.pone.0323253
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00